Attached files

file filename
8-K - FORM 8-K - CTI BIOPHARMA CORPd8k.htm

Exhibit 16.1

October 6, 2010

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549-7561

We have read Item 4.01 included in the Current Report on Form 8-K of Cell Therapeutics, Inc. dated October 1, 2010, to be filed with the Securities and Exchange Commission on October 6, 2010. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree to disagree with other statements of Cell Therapeutics, Inc. contained therein.

 

/s/  Stonefield Josephson, Inc.

Stonefield Josephson, Inc.